Current Trials

F03025 – Pneumococcal Vaccine Trial

 Fusion Clinical Research Norwood

Adults aged 50–64 may be eligible for a clinical trial evaluating a new pneumococcal vaccine.

The study includes 6 visits over 6 months. Participants receive compensation for their time.

Sign up below to see if you qualify.

Fusion Website - Featured Image Pneumococcal

Eligibility requirements

  • Age: 50-64
  • Sex: M & F
  • BMI: <40
  • Medication: Cannot have received any pneumococcal vaccine previously
  • Medical History: Eligibility requirements (not limited to): Adults aged 50–64, In good health or with stable medical conditions, No history of serious pneumococcal infection in the past 3 years, Not immunocompromised.

Overnight Stays

  • Nil

Outpatient Visits

  • 6 visits over 6 months.

Payment/Remuneration

  • $250 for each study visit, plus $10 per day of eDiary completion.

How to apply

To register your interest in this trial, please complete the form below, or call us on 1800-FUSION (1800 387 466). A Fusion team member will be in contact to discuss your eligibility shortly.